The impact of CYP2C19 genotype on phenoconversion by concomitant medication

被引：0
|
作者：
De Jong, Laura [1 ]
Boussallami, Soukayna [1 ]
Hawinkels, Luuk [4 ]
Hoekstra, Menno [1 ]
Tushuizen, Maarten [4 ]
Rissmann, Robert [3 ]
Swen, Jesse [2 ]
Manson, Martijn [1 ]
机构：
[1] Leiden Acad Ctr Drug Res, Div Syst Pharmacol & Pharm, Leiden, Netherlands
[2] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands
[3] Leiden Univ, Ctr Human Drug Res, Med Ctr, Leiden, Netherlands
[4] Leiden Univ, Dept Gastroenterol Hepatol, Med Ctr, Leiden, Netherlands
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0547
引用
收藏
页码：1326 / 1327
页数：2
相关论文
共 50 条
  • [1] The impact of CYP2C19 genotype on phenoconversion by concomitant medication
    de Jong, Laura M.
    Boussallami, Soukayna
    Sanchez-Lopez, Elena
    Giera, Martin
    Tushuizen, Maarten E.
    Hoekstra, Menno
    Hawinkels, Lukas J. A. C.
    Rissmann, Robert
    Swen, Jesse J.
    Manson, Martijn L.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [2] Rapid CYP2C19 Genotype Testing: Comparison between Spartan RX CYP2C19 and Verigene CYP2C19
    Zhou, Y.
    Armstead, A. R.
    Coshatt, G. M.
    Brott, B. C.
    Sankaranarayanan, A.
    Limdi, N. A.
    Harada, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 845 - 845
  • [3] The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics
    Scherf-Clavel, Maike
    Weber, Heike
    Unterecker, Stefan
    Frantz, Amelie
    Eckert, Andreas
    Reif, Andreas
    Deckert, Juergen
    Hahn, Martina
    PHARMACOPSYCHIATRY, 2024, 57 (02) : 69 - 77
  • [4] CYP2C19 Genotype and Cardiovascular Events
    Mega, Jessica L.
    Topol, Eric J.
    Sabatine, Marc S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (14): : 1482 - 1483
  • [5] CYP2C19 genotype: a moving target?
    Zembles, Tracy N.
    Marcuccilli, Charles J.
    Sander, Tara L.
    Simpson, Pippa
    PHARMACOTHERAPY, 2012, 32 (10): : E236 - E236
  • [6] Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction
    Kiss, Adam Ferenc
    Vasko, Dorottya
    Deri, Mate Tamas
    Toth, Katalin
    Monostory, Katalin
    PHARMACOLOGICAL REPORTS, 2018, 70 (03) : 525 - 532
  • [7] Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction
    Ádám Ferenc Kiss
    Dorottya Vaskó
    Máté Tamás Déri
    Katalin Tóth
    Katalin Monostory
    Pharmacological Reports, 2018, 70 : 525 - 532
  • [8] Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity
    Lesche, Dorothea
    Mostafa, Sam
    Everall, Ian
    Pantelis, Christos
    Bousman, Chad A.
    PHARMACOGENOMICS JOURNAL, 2020, 20 (02): : 192 - 201
  • [9] Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity
    Dorothea Lesche
    Sam Mostafa
    Ian Everall
    Christos Pantelis
    Chad A. Bousman
    The Pharmacogenomics Journal, 2020, 20 : 192 - 201
  • [10] CYP2C19 PHENOCONVERSION IN PATIENTS WITH BREAST CANCER AND ALTERATIONS IN BIOACTIVATION OF CYCLOPHOSPHAMIDE
    Helsby, N.
    Yang, J.
    Goldthorpe, M.
    Barrett, C.
    Wilson, G.
    Broom, R.
    Findlay, M.
    Porter, D.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E41 - E41
12345